We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.64B
Cap. Flow %
-83.08%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Real Estate 7.26%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNVTW
476
DELISTED
Finnovate Acquisition Corp. Warrants
FNVTW
$1.77K ﹤0.01%
130,406
SPECW
477
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$1.76K ﹤0.01%
231,101
H icon
478
PUT
Hyatt Hotels
H
$16.7B
$1.5K ﹤0.01%
12,000
-90,000
-88% -$10.2M
PUCKW
479
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$1.42K ﹤0.01%
283,281
RARE icon
480
CALL
Ultragenyx Pharmaceutical
RARE
$2.51B
$1.25K ﹤0.01%
10,000
-85,000
-89% -$3.3M
FICVW
481
DELISTED
Frontier Investment Corp Warrants
FICVW
$1.17K ﹤0.01%
32,524
AENTW icon
482
Alliance Entertainment Holding Corp Warrants
AENTW
$4.27M
$993 ﹤0.01%
116,781
HLT icon
483
PUT
Hilton Worldwide
HLT
$71.9B
$700 ﹤0.01%
14,000
OMF icon
484
PUT
OneMain Financial
OMF
$7.42B
$502 ﹤0.01%
20,100
EXPE icon
485
PUT
Expedia Group
EXPE
$36.8B
$440 ﹤0.01%
11,000
DKNG icon
486
PUT
DraftKings
DKNG
$11.6B
$412 ﹤0.01%
82,500
WINVW
487
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$208 ﹤0.01%
18,392
AAL icon
488
American Airlines Group
AAL
$10.6B
-50,000
Closed -$628K
ABOS icon
489
Acumen Pharmaceuticals
ABOS
$170M
-69,538
Closed -$289K
ACRS icon
490
CALL
Aclaris Therapeutics
ACRS
$814M
-70,000
Closed -$117K
ACRS icon
491
Aclaris Therapeutics
ACRS
$814M
-68,014
Closed -$466K
AEM icon
492
Agnico Eagle Mines
AEM
$90.3B
-100,000
Closed -$4.54M
AES icon
493
AES
AES
$10.5B
-422,400
Closed -$6.42M
ALGN icon
494
Align Technology
ALGN
$12.1B
-5,300
Closed -$1.62M
ALLY icon
495
PUT
Ally Financial
ALLY
$13.3B
-175,000
Closed -$228K
ALNY icon
496
CALL
Alnylam Pharmaceuticals
ALNY
$28.9B
-14,000
Closed -$21.3K
ALNY icon
497
PUT
Alnylam Pharmaceuticals
ALNY
$28.9B
-10,000
Closed -$14.3K
AMLX icon
498
Amylyx Pharmaceuticals
AMLX
$2.58B
-35,000
Closed -$641K
AMSC icon
499
CALL
American Superconductor
AMSC
$1.59B
-30,500
Closed -$11.4K
ANNX icon
500
CALL
Annexon
ANNX
$893M
-300,000
Closed -$30K

Similar funds

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.64B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.